Skip to navigation Skip to content

Managing disease-modifying therapy in multiple sclerosis


October 24, 2013 - November 24, 2014
12:00 AM

In Person


The complexity of MS patient management is increasing dramatically, based on the growth of novel disease modifying therapy options. One of the most challenging issues to face neurologists in the coming years is the integration of these newer therapies into their clinical armamentarium. This patient centered CME/CNE program allows MS treating clinicians to learn in the context of actual MS patients. With new disease modifying therapies available and emerging, there is a unique opportunity to provide educational experiences in the context of real world referrals that can alter long-term practice patterns.

This activity is intended for healthcare professionals, specifically, neurologists, internists, family practice physicians, nurse practitioners, physician assistants, registered nurses and other providers involved in the care of patients with multiple sclerosis.The University of Texas Southwestern Medical Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. This educational activity for 0.5 contact hours is provided for nurses by Postgraduate Institute for Medicine. No fee.

Visit the website